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BackgroundzzMononeuropathy multiplex is a rare complication during the course of chronic he-
patitis B, despite various neuropathies following acute hepatitis B having been reported previously.
Case ReportzzA 30-year-old man presented with sensorimotor symptoms in multiple peripheral 
nerves. The serological tests for hepatitis were consistent with chronic active hepatitis B. After treat-
ment with oral prednisone combined with an antiviral agent, the sensory and motor symptoms im-
proved and hepatitis B virus replication was reduced.
ConclusionszzWe suggest that chronic immune-mediated neuropathy associated with hepatitis 
B virus infection should be considered in the differential diagnosis of patients with hepatitis B.
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Introduction
Among the several types of hepatitis, chronic active hepatitis 
B can cause peripheral neuropathies by vascular- or immune-
mediated pathology.
1,2 Previously reported neuropathies in 
patients with hepatitis B virus (HBV) infection include vascu-
lar neuropathies such as polyarteritis nodosa (PAN) and demy-
elinating neuropathies such as chronic inflammatory demyelin-
ating polyneuropathy and Guillain-Barré syndrome.
3 However, 
chronic immune-mediated, nonvasculitic mononeuropathy mul-
tiplex (MM) in association with chronic hepatitis B has been 
reported only rarely. We report a case of HBV-related multi-
ple axonal neuropathy that mimicked vasculitic MM, and was 
complicated by chronic active hepatitis B.
Case Report
A 30-year-old, male HBV carrier complained of pricking and 
burning discomfort in the distal potions of the first to third fin-
gers of the left hand, and dysesthesia of the left foot of 2 mon-
ths duration. Despite treatment with medication for the pain 
at another hospital, the sensory symptoms progressed. By 5 
weeks after the onset of the initial symptoms the patient had 
new complaints of difficulty with extension of the left ankle 
joint and flexion of all of the fingers on the left hand except 
for the fifth finger. Just prior to admission to the hospital, par-
esthesia of the right hand and foot developed. On admission 
to the hospital, his blood pressure was 120/80 mmHg. The pa-
tient had decreased deep tendon reflexes at all four extremities. 
The initial nerve conduction study (NCS) findings suggested 
a multifocal sensorimotor mononeuropathy of the axonal type 
(Table 1 and 2).
An extensive workup for the etiology of MM including fast-
ing blood sugar, cerebrospinal fluid examination, and tests for 
cryoglobulin and immunoglobulins (IgM, IgG, IgA, and IgE) 
with serum protein electrophoresis, antinuclear, antineutro-
phil cytoplasmic, anti-SS-A/B, anti-centromere, anti-SCL70, 
anti-dsDNA, anti-SM, anti-cardiolipin antibodies, rheuma-
toid factor, proteins C and S, CH50/C3/C4 complement, lupus-
anticoagulant, and thyroid function were negative. However, 
chronic active hepatitis B was diagnosed by hepatitis serology 
testing as follows: 1) positive HBsAg, HBeAg, HBV PCR, 
and anti-HBc, 2) markedly increased titers of HBV DNA 
(124 ng/mL), and 3) negative anti-HBs and anti-HBe. Aspar-
tate aminotransferase and alanine aminotransferase levels 
were elevated (47 and 85 U/mL, respectively), but the eryth- Nam TS et al.
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rocyte sedimentation rate, and blood urea nitrogen, and se-
rum creatinine levels were all within normal limits.
We initially thought that our patient had hepatitis-B-related 
PAN because he had three of the associated features (i.e., MM, 
chronic HBV infection, and myalgia), as per the American 
College of Rheumatology 1990 criteria for the diagnosis of 
PAN.
4 Treatment with methylprednisolone pulse therapy (1 g 
intravenously for three consecutive days) followed by oral 
prednisone (1 mg/kg/day) was started together with an anti-
viral agent (100 mg lamivudine).
A left sural nerve biopsy revealed no evidence of inflam-
matory cell infiltration or necrotic changes in the vessels walls. 
Semithin slabs of the sural nerve exhibited markedly reduced 
numbers of myelin fibers. We performed abdominal visceral 
angiography on the hepatic, renal, and superior mesenteric ar-
teries to rule out systemic vasculitis. The results of the angiog-
raphy were within normal limits and did not reveal multiple 
small aneurysms or arterial constrictions. The sensory and 
motor symptoms had improved 2 months later, and the HBV 
replication was reduced (follow-up HBV DNA: 2,230 pg/
mL). The follow-up NCS showed improvement in the com-
pound motor action potential and sensory nerve action poten-
tial (SNAP) amplitudes compared to the previous NCS find-
ings, except for an absent SNAP over the finger-to-wrist seg-
ments of the left median nerve (Table 1 and 2).
Discussion
MM is a painful asymmetric sensory and motor peripheral neu-
ropathy involving isolated damage to at least two separate 
nerve areas. It is a syndrome of diverse causes including dia-
betes mellitus, demyelinating, infectious, or neoplastic etiol-
Table 1. Results of motor nerve conduction studies at baseline and follow-up
RT/LT
nerve
Segment
Baseline 2-months follow-up
Latency (ms) Amplitude (mV) NCV (m/s) Latency (ms) Amplitude (mV) NCV (m/s)
Median TL 3.1/3.4 6.7/2.1 3.4/3.5 9.3/8.4
E-W 6.4/1.8 52.2/50.0 9.5/7.5 50.0/44.2
AX-E 6.3/1.7 52.2/55.0 9.4/8.8 70.6/76.9
F-wave NP/NP 22.6/26.6
Ulnar TL 2.5/2.9 9.6/9.8 2.5/2.5
BE-W 9.4/8.8 56.8/62.1 11.1/17.4 67.6/48.6
AE-BE 9.0/8.7 53.8/80.8 10.7/16.3 54.1/61.5
AX-AE 8.6/8.7 58.8/61.5 10.4/16.2 60.2/60.8
F-wave 26.0/27.2 27.0/25.3
Tibial TL 5.4/5.7 6.1/6.2 3.8/3.8 9.3/10.0
PF-A 5.5/4.8 46.5/45.7 8.5/8.0 44.8/45.5
F-wave 55.1/53.1 50.2/51.3
Peroneal TL 4.2/4.6 8.0/1.3 3.3/3.4 6.0/4.6
FH-A 7.7/1.4 46.8/40.4 5.4/4.0 42.3/40.0
PF-FH 7.8/1.2 39.7/45.0 4.8/4.0 58.8/60.4
F-wave 47.3/NP 45.1/48.1
RT: right, LT: left, NCV: nerve conduction velocity, TL: terminal latency, E: elbow, W: wrist, AX: axilla, BE: below elbow, AE: above elbow, 
PF: popliteal fossa, A: ankle, FH: fibular head, NP: no potential.
Table 2. Results of sensory nerve conduction studies at baseline and follow-up
RT/LT
nerve
Segment
Baseline 2-months follow-up
Amplitude (uV) NCV (m/s) Amplitude (uV) NCV (m/s)
Median F-W 04.2/NP 44.8/NP 09.4/NP 46.4/NP
P-W 13.0/NP 44.4/NP 16.0/NP 47.2/NP
W-E 20.0/6.10 55.3/55.6 15.0/4.90 52.8/52.6
E-AX 17.4/6.10 54.7/56.9 19.0/30.0 75.0/61.1
Ulnar F-W 13.7/14.0 46.4/45.8 9.1/9.8 53.8/44.8
W-E 19.0/11.0 56.1/54.3 15.0/36.0 49.8/62.9
E-AX 14.7/14.0 62.1/60.3 13.0/31.0 45.5/68.4
Radial W-F 05.5/12.0 47.4/46.2 11.0/10.5 53.8/51.6
Sural MC-A 5.4/4.6 37.1/34.2 11.0/7.50 53.8/41.7
RT: right, LT: left, NCV: nerve conduction velocity, F: finger, P: palm, F: forearm, MC: middle calf.Chronic Active Hepatitis B and Mononeuropathy Multiplex
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ogy. In association with chronic active hepatitis B, MM asso-
ciated with PAN is relatively common. Our case manifested 
with multifocal sensorimotor mononeuropathy accompanied 
by chronic active hepatitis B, similar to vasculitic neuropathies 
such as PAN. PAN is a necrotizing vasculitis of medium-sized 
arteries; its most prominent clinical manifestations include 
variable signs such as MM, weight loss, livedo reticularis, hy-
pertension, abnormal renal blood tests, myalgia and arthritis, 
testicular pain, HBV infection, evidence of vasculitis on ab-
dominal angiography, and abnormal nerve biopsy. The pres-
ence of three or more of these ten factors is associated with 
PAN with a sensitivity of 82.2% and a specificity of 86.6%.
4 
Furthermore, HBV infection has been reported in around 30% 
of patients with PAN, although PAN is a rare complication of 
hepatitis B.
1,5 In our patient, a sural nerve biopsy did not dis-
close evidence of vasculitis, despite marked loss of myelin-
ated fibers. However, the absence of vasculitis in the biopsy 
specimens dose not exclude vasculitis for several reasons: 1) 
multifocal vasculitis may occur in a more proximal part of 
the nerve (sampling bias), 2) the confirmative rate of specific 
vasculitis by biopsy is low,
6 and 3) sural nerve biopsy results 
may only provide information about the small arteries, there-
by missing the vasculitis of medium-sized arteries (as in PAN). 
We therefore performed abdominal visceral angiography to 
seek evidence of vasculitis in the medium-sized to small arter-
ies; the sensitivity and specificity of abdominal angiography 
in PAN are reported to be 89% and 90%, respectively. Accord-
ing to Hekali, 2- to 5-mm-sized and multiple (≥10) aneurysms 
on abdominal angiography are strongly supportive of a diag-
nosis of PAN.
7 Furthermore, the evidence of vasculitis in 80% 
of all patients with PAN may be established angiographically, 
although the clinical significance of angiography for investi-
gation in suspected PAN might be controversial.
8 In our case, 
we thought that the diagnosis could be nonsystemic small-
vessel vasculitic neuropathy associated with HBV infection, 
although negative hisotopathologic and angiographic results 
do not completely exclude the presence of localized PAN.
In general, an immune-mediated neuropathy should be con-
sidered if other causes of multifocal neuropathies, including 
diabetes mellitus and vasculitic neuropathies, have been exclud-
ed.
9 The beneficial response to steroid treatment also raised the 
possibility of a chronic immune-mediated neuropathy. The ch-
ronic immune-mediated neuropathies are a diverse group of 
disorders that result from immune-mediated damage to the pe-
ripheral nerves. Chronic hepatitis B is not only a recognized 
risk factor for the development of an immune-mediated neu-
ropathy, but also a common infection, with it being estimated 
that there are more than 300 million sufferers worldwide.
10 The 
underlying pathology and mechanisms of the peripheral neu-
ropathy following HBV infection have not been elucidated. 
However, immune-mediated neuronal damage secondary to 
the direct action of the virus itself on the nerve fibers, or depo-
sition of immune complexes of HBsAg and HBeAg on the 
vasa nervorum can lead to peripheral neuropathies. In addi-
tion, viral replication might be an important factor in the dis-
ease activity or pathogenesis, as suggested by the high titers 
of HBV DNA and the improvement in clinical symptoms after 
the administration of antiviral agents.
11 Our patient improved 
clinically with the gradual attenuation of HBV replication af-
ter treatment with lamivudine.
In summary, we have presented an interesting case with ste-
roid-responsive sensorimotor MM associated with chronic ac-
tive hepatitis B that was not accompanied by any evidence of 
vasculitis. Early diagnosis and treatment in an immune-me-
diated neuropathy are very important for the control of disease 
activity and progression. If peripheral sensory or motor symp-
toms develop in patients with hepatitis B, chronic immune-me-
diated neuropathy associated with HBV infection should be 
considered in the differential diagnosis.
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